Immunodeficient patients are less prone to develop serious complications of COVID-19 and cytokine storm. However, they are more likely to develop opportunistic infections that can mimic the symptoms of the SARS-CoV-2. we presented a 27-year-old male case of SARS-CoV-2, who was complicated with Pneumocystis jirovecii pneumonia, following treatment with rituximab.